Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | HRS-6209 |
| Synonyms | |
| Therapy Description |
HRS-6209 is a CDK4 inhibitor, which potentially inhibits tumor growth (Cancer Res (2026) 86 (8_Supplement): CT117). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| HRS-6209 | HRS6209|HRS 6209 | CDK4 Inhibitor 20 | HRS-6209 is a CDK4 inhibitor, which potentially inhibits tumor growth (Cancer Res (2026) 86 (8_Supplement): CT117). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|